Disclaimer: That Intended For Medical Professionals Only

Log In/Register

Latest News :

New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management • New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management •

Best Seller ILATAB

ILATAB

ILATAB

Elagolix

150/200mg

Dosage Form & Strength

150mg OD or 200mg BD Half Life: 4-6h

Overview

Orilissa

Indications

Endometriosis pain

Contraindications

Pregnancy, osteoporosis, severe liver disease

Adverse Effects

Hot flush, headache

Special Warnings & Precautions

Monitor bone density

Drug Interactions

CYP3A/OATP

Mechanism of Action

GnRH antagonist

Pharmacokinetics

Suppresses ovarian hormones

Absorption, Distribution, Metabolism & Excretion

Absorption : Rapid; Tmax 1h CYP3A Metabolism Feces 90% Excretion

Drug Use in Pregnancy

Contraindicated

Drug Use in Renal Impairment

Caution

Drug Use in Hepatic Impairment

Avoid severe

Drug Use in Pediatric Population

Not indicated

Drug Use in Geriatric Population

Caution

More Related Product

Subscribe to our newsletter

Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.